SPONSOR
Daewoong Pharmaceutical Co. LTD.
Total Trials
3
Recruiting
3
Phases
Phase 1
Daewoong Pharmaceutical Co. LTD. is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Healthy Volunteers, Gastritis, Cancer, Ovarian Cancer.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Daewoong Pharmaceutical Co. LTD.
How many clinical trials has Daewoong Pharmaceutical Co. LTD. sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Daewoong Pharmaceutical Co. LTD., of which 3 are actively recruiting participants. These trials cover conditions including Healthy Volunteers, Gastritis, Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Daewoong Pharmaceutical Co. LTD. research focus on?
Daewoong Pharmaceutical Co. LTD. clinical trials span Healthy Volunteers, Gastritis, Cancer, Ovarian Cancer. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Daewoong Pharmaceutical Co. LTD. clinical trial?
To participate in a Daewoong Pharmaceutical Co. LTD. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Daewoong Pharmaceutical Co. LTD. trials with current recruitment status updated daily.
Clinical Trials by Daewoong Pharmaceutical Co. LTD.
NCT07267221 Phase 1
Recruiting
Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.
Healthy Volunteers
NCT06948487
Recruiting
Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis
Gastritis
NCT07371104 Phase 1
Recruiting
Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer
Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology